Amkay Products

What does Amkay Products do?

Amkay Products Ltd is a micro-cap company in the healthcare services industry, recently converted to a public limited company. It has a market cap of Rs 36 Cr, with key metrics including a P/E ratio of 11.00 and a return on equity of 33.40%.

Overview:<BR>Amkay Products Ltd operates in the healthcare services industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Amkay Products Ltd was originally incorporated as "Amkay Products Private Limited" in 2007. It was later converted into a Public Limited Company, with the name changed to "Amkay Products Limited" on August 28, 2023. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: Rs 36 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 11.00<BR>Industry P/E: 53<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 0.54<BR>Return on Equity: 33.40%<BR>Price-to-Book: 3.60<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Has Amkay Products declared dividend?

No Dividend History Available

Who are the peers of the Amkay Products?

Amkay Products' peers include Syngene Intl., Dr Lal Pathlabs, Poly Medicure, and others. While Poly Medicure leads with a 1-year return of 24.45%, Amkay Products has the lowest at -34.33%, indicating weaker performance compared to its peers.

Peers: The peers of Amkay Products are Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., Transgene Biotek, Samsrita Labs, Shree Pacetronix, and Adeshwar Meditex.<BR><BR>Quality Snapshot: Excellent management risk is observed at Dr Lal Pathlabs, while Good management risk is found at Syngene Intl., Poly Medicure, Indegene, Vijaya Diagnost., Amkay Products, and Shree Pacetronix, and the rest. Below Average management risk is noted at Adeshwar Meditex. Growth is rated as Excellent for none, Below Average for Dr Lal Pathlabs, Vijaya Diagnost., and Amkay Products, Average for Poly Medicure, Indegene, and the rest. Capital Structure is rated as Excellent for Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., and Shree Pacetronix, while Average is noted for Amkay Products, and Below Average for Adeshwar Meditex.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Poly Medicure at 24.45%, while Amkay Products has the lowest at -34.33%. Amkay Products' 1-year return is significantly lower than that of its peers. Additionally, the six-month return is negative for Syngene Intl., Poly Medicure, Vijaya Diagnost., Transgene Biotek, Shree Pacetronix, and Adeshwar Meditex.

What is the technical trend for Amkay Products?

As of May 29, 2025, Amkay Products is in a mildly bearish trend, indicated by daily moving averages and weekly Bollinger Bands, despite a mildly bullish weekly MACD and mixed signals from Dow Theory, with the stock underperforming relative to the Sensex.

As of 29 May 2025, the technical trend for Amkay Products has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages indicating bearish momentum and the weekly Bollinger Bands also reflecting a bearish outlook. The weekly MACD shows a mildly bullish signal, but this is countered by the overall bearish sentiment from the daily indicators. The Dow Theory presents a mixed view with a mildly bearish weekly signal and a mildly bullish monthly signal. The stock's performance relative to the Sensex shows significant underperformance across multiple time frames, further supporting the bearish outlook.

Who are the top shareholders of the Amkay Products?

The top shareholder of Amkay Products is Kashyap Pravin Mody, holding 30.95%, with no pledged promoter holdings. The highest public shareholder is Rakesh Khanna at 1.11%, while individual investors collectively own 23.23% of the shares.

The top shareholders of Amkay Products primarily consist of the promoters, with Kashyap Pravin Mody holding the highest stake at 30.95%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Rakesh Khanna, who owns 1.11% of the shares. Additionally, individual investors collectively hold 23.23% of the company's shares.

How big is Amkay Products?

As of 24th July, Amkay Products Ltd has a market capitalization of 53.00 Cr, classified as a Micro Cap, with no valid financial data available for Net Sales or Net Profit for the latest four quarters. The balance sheet as of March 2024 shows Shareholder's Funds at 10.00 Cr and Total Assets at 17.74 Cr.

As of 24th July, <BR><BR>Market Cap: Amkay Products Ltd has a market capitalization of 53.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds valued at 10.00 Cr and Total Assets amounting to 17.74 Cr.

Is Amkay Products overvalued or undervalued?

As of September 15, 2025, Amkay Products is considered undervalued with a PE ratio of 13.61 and an EV to EBITDA of 11.27, making it more attractive compared to its peers, despite a year-to-date stock performance decline of -15.87% against the Sensex's 4.67% return.

As of 15 September 2025, the valuation grade for Amkay Products has moved from very expensive to very attractive, indicating a significant shift in its market perception. The company is currently assessed as undervalued. Key ratios supporting this conclusion include a PE ratio of 13.61, an EV to EBITDA of 11.27, and a ROE of 13.88%. <BR><BR>In comparison to its peers, Amkay Products stands out with a much lower PE ratio than Poly Medicure (56.25) and Blue Jet Health (34.63), both categorized as very expensive. This suggests that Amkay Products offers a more favorable valuation relative to its competitors. Despite a recent decline in stock performance compared to the Sensex, where it has underperformed with a year-to-date return of -15.87% against the Sensex's 4.67%, the underlying financial metrics indicate that the company is positioned well for potential growth.

When is the next results date for Amkay Products?

Amkay Products will announce its results on 12 November 2025.

Amkay Products will declare its results on 12 November 2025.

How has been the historical performance of Amkay Products?

Amkay Products has shown fluctuating performance over the past five years, with net sales increasing to 38.39 Cr in March 2025 from 31.07 Cr in March 2024, alongside improvements in profits and total assets, indicating a positive trend in recent years.

Answer:<BR>The historical performance of Amkay Products shows a fluctuating trend in net sales and profits over the past five years.<BR><BR>Breakdown:<BR>Amkay Products reported net sales of 38.39 Cr in March 2025, an increase from 31.07 Cr in March 2024 and 27.86 Cr in March 2023, although it was lower than the 40.70 Cr in March 2021. The total operating income followed a similar pattern, reaching 38.39 Cr in March 2025. The company's total expenditure, excluding depreciation, was 34.26 Cr in March 2025, up from 27.74 Cr in March 2024. Operating profit (PBDIT) increased to 5.45 Cr in March 2025 from 4.58 Cr in March 2024, while profit before tax rose to 4.30 Cr in March 2025 from 3.50 Cr in March 2024. Profit after tax also improved to 3.34 Cr in March 2025 compared to 2.63 Cr in March 2024. The company's total assets increased to 29.63 Cr in March 2025 from 17.74 Cr in March 2024, with total liabilities also rising to 29.63 Cr. The cash flow from financing activities showed a positive trend with a net cash inflow of 1.00 Cr in March 2025, indicating improved liquidity. Overall, while Amkay Products experienced some fluctuations, the recent years show a positive trajectory in sales and profitability.

Why is Amkay Products Ltd falling/rising?

As of 20-Mar, Amkay Products Ltd's stock price is rising to 57.00, driven by increased investor participation and a positive performance over the past week, despite a monthly decline. The stock remains above its 200-day moving average and has shown a strong yearly gain of 29.46%, contrasting with the Sensex's decline.

As of 20-Mar, Amkay Products Ltd's stock price is rising, currently at 57.00, with a change of 0.32 (0.56%) upward. This increase can be attributed to several factors highlighted in the data. Notably, the stock has shown a positive performance over the past week, gaining 0.56%, while the benchmark Sensex has slightly declined by 0.04%. Additionally, there has been a significant rise in investor participation, with delivery volume increasing by 42.86% against the 5-day average, indicating growing interest in the stock.<BR><BR>Despite some erratic trading patterns, as the stock did not trade on 5 out of the last 20 days, it remains above the 200-day moving average, which suggests a longer-term positive trend. However, it is important to note that the stock has experienced a decline of 4.76% over the past month and a year-to-date drop of 7.69%. Nevertheless, its strong performance over the past year, with a gain of 29.46%, contrasts with the negative performance of the Sensex, which has fallen by 2.38% in the same period. This combination of recent upward movement, increased trading activity, and strong yearly performance contributes to the current rise in Amkay Products Ltd's stock price.

Why is Amkay Products Ltd falling/rising?

As of 23-Mar, Amkay Products Ltd's stock price is at Rs 54.50, reflecting a 4.39% decline. The stock has underperformed its sector and has seen significant decreases over the past week, month, and year-to-date, indicating a bearish trend.

As of 23-Mar, Amkay Products Ltd's stock price is falling, currently at Rs 54.50, which reflects a decrease of Rs 2.5 or 4.39%. This decline is evident from the stock's performance today, where it opened with a loss of 4.39% and reached an intraday low of Rs 54.50. Additionally, the stock has underperformed its sector by 1.02%. <BR><BR>Over the past week, the stock has decreased by 3.85%, while the broader market, represented by the Sensex, has only fallen by 3.72%. In the last month, Amkay Products Ltd has seen a more significant decline of 8.94%, compared to the Sensex's drop of 12.72%. Year-to-date, the stock is down 11.74%, while the Sensex has decreased by 14.70%. <BR><BR>The stock's trading activity has also been erratic, with no trades occurring on 4 out of the last 20 days. Furthermore, there has been a notable decrease in investor participation, as evidenced by a 37.5% drop in delivery volume on March 20 compared to the 5-day average. The overall sector, which includes Medical Equipment/Supplies/Accessories, has also experienced a decline of 3.49%. <BR><BR>While the stock is trading above its 200-day moving average, it is below its 5-day, 20-day, 50-day, and 100-day moving averages, indicating a bearish trend in the short to medium term. These factors collectively contribute to the downward movement of Amkay Products Ltd's stock price.

Why is Amkay Products Ltd falling/rising?

As of 24-Mar, Amkay Products Ltd's stock price is at Rs 57.90, up 6.24%, outperforming its sector by 2.83%. Increased investor participation and a positive trend in the medical equipment sector contribute to its strong performance, despite some erratic trading patterns.

As of 24-Mar, Amkay Products Ltd's stock price is rising, currently at Rs 57.90, reflecting a change of Rs 3.4 or 6.24%. This increase is notable as the stock has outperformed its sector by 2.83% today. The stock also reached an intraday high of Rs 57.90, indicating strong performance within the trading day. <BR><BR>Additionally, there has been a significant rise in investor participation, with delivery volume on 23 March increasing by 150% compared to the 5-day average. This suggests heightened interest and confidence among investors. Furthermore, the medical equipment sector, in which Amkay operates, has gained by 2.57%, contributing positively to the stock's performance.<BR><BR>Despite some erratic trading patterns, where the stock did not trade on 3 out of the last 20 days, it remains liquid enough for trading. The stock's current price is higher than its 100-day and 200-day moving averages, although it is lower than the 5-day, 20-day, and 50-day moving averages. This mixed moving average performance indicates that while there are short-term fluctuations, the overall trend appears to be positive at this moment.

Why is Amkay Products Ltd falling/rising?

As of 25-Mar, Amkay Products Ltd's stock price is stable at Rs 57.90, with a recent short-term gain of 2.15% despite a longer-term decline of 6.23% year-to-date. Increased investor participation and positive sector performance indicate potential rising interest in the stock.

As of 25-Mar, Amkay Products Ltd's stock price is currently stable at Rs 57.90, showing no change (0.00%). However, the stock has demonstrated a mixed performance over various periods. In the past week, it has risen by 2.15%, outperforming the Sensex, which fell by 1.87%. This short-term gain may be attributed to positive sector performance, as the Medical Equipment/Supplies/Accessories sector has gained by 2.57%.<BR><BR>Despite this recent uptick, the stock has experienced a decline of 3.26% over the past month and a year-to-date decrease of 6.23%. This suggests that while there may be short-term gains, the overall trend has been downward in the longer term. The stock has also outperformed the sector by 2.83% today, indicating some investor confidence.<BR><BR>Moreover, there has been a notable increase in investor participation, with delivery volume rising by 150% against the 5-day average, which could signal growing interest in the stock. However, the stock's erratic trading—having not traded on 3 out of the last 20 days—may contribute to volatility in its price movements.<BR><BR>In summary, while Amkay Products Ltd is currently stable, recent short-term gains and increased investor participation suggest a potential for rising interest, despite longer-term declines in price.

Which are the latest news on Amkay Products?